CCL2 and breast cancer: The impact of this signaling pathway is further magnified by the direct interaction between β-catenin and the CCL2 promoter, which amplifies the characteristics of breast cancer stem cells, thus potentiating the aggressive nature of TNBC (Zhang F. et al., 2021; Tigue et al., 2023).